Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Elicio Therapeutics Inc.

    NASDAQ: ELTX · Real-Time Price · USD
    8.01
    0.05 (0.63%)
    At close: Jun 20, 2025, 2:46 PM

    Elicio Therapeutics Statistics

    Share Statistics

    Elicio Therapeutics has 16M shares outstanding. The number of shares has increased by 54.44% in one year.

    Shares Outstanding

    n/a
    		 16M

    Shares Change (YoY)

    n/a
    		 54.44%

    Shares Change (QoQ)

    n/a
    		 46.99%

    Owned by Institutions (%)

    n/a
    		 3.72%

    Shares Floating

    n/a
    		 6.67M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,894

    FTD / Avg. Volume

    n/a
    		 13.87%

    Short Selling Information

    The latest short interest is 168.48K, so 1.05% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 168.48K

    Short % of Shares Out

    n/a
    		 1.05%

    Short % of Float

    n/a
    		 1.63%

    Short Ratio (days to cover)

    n/a
    		 4.2

    Valuation Ratios

    The PE ratio is -1.2 and the forward PE ratio is -6.58. Elicio Therapeutics's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -1.2

    Forward PE

    n/a
    		 -6.58

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -5.5

    P/FCF Ratio

    n/a
    		 -1.68

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Elicio Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.8, with a Debt / Equity ratio of -2.3.

    Current Ratio

    n/a
    		 1.8

    Quick Ratio

    n/a
    		 1.8

    Debt / Equity

    n/a
    		 -2.3

    Debt / EBITDA

    n/a
    		 -0.52

    Debt / FCF

    n/a
    		 -0.7

    Interest Coverage

    n/a
    		 -98.87

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,621,812.5

    Employee Count

    n/a
    		 32

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 20.24% in the last 52 weeks. The beta is 2.16, so Elicio Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.16

    52-Week Price Change

    n/a
    		 20.24%

    50-Day Moving Average

    n/a
    		 6.06

    200-Day Moving Average

    n/a
    		 6.02

    Relative Strength Index (RSI)

    n/a
    		 62.47

    Average Volume (20 Days)

    n/a
    		 42,504

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -44.99M

    Net Income

    n/a
    		 -51.9M

    EBITDA

    n/a
    		 -50.27M

    EBIT

    n/a
    		 -52.35M

    Earnings Per Share (EPS)

    n/a
    		 -4.25
    Full Income Statement

    Balance Sheet

    The company has 17.62M in cash and 26.04M in debt, giving a net cash position of -8.42M.

    Cash & Cash Equivalents

    n/a
    		 17.62M

    Total Debt

    n/a
    		 26.04M

    Net Cash

    n/a
    		 -8.42M

    Retained Earnings

    n/a
    		 -194.1M

    Total Assets

    n/a
    		 28.14M

    Working Capital

    n/a
    		 9.52M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -37.07M and capital expenditures -87K, giving a free cash flow of -37.16M.

    Operating Cash Flow

    n/a
    		 -37.07M

    Capital Expenditures

    n/a
    		 -87K

    Free Cash Flow

    n/a
    		 -37.16M

    FCF Per Share

    n/a
    		 -3.04
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ELTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ELTX is $9.5, which is 19.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9.5

    Price Target Difference

    n/a
    		 19.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 2, 2023. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jun 2, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -10.97

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist